These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 2972431

  • 21. [Defects of adrenal steroidogenesis in patients with hirsutism].
    Salinas Vert I, Audí Parera L, Granada Ybern ML, Lucas Martín A, Pizarro Lozano E, Foz Sala M, Sanmartí Sala A.
    Med Clin (Barc); 1998 Feb 14; 110(5):171-6. PubMed ID: 9547720
    [Abstract] [Full Text] [Related]

  • 22. Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.
    Narimoto K, Mizokami A, Izumi K, Mihara S, Sawada K, Sugata T, Shimamura M, Miyazaki K, Nishino A, Namiki M.
    Int J Urol; 2010 Apr 14; 17(4):337-45. PubMed ID: 20202011
    [Abstract] [Full Text] [Related]

  • 23. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
    Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D.
    N Engl J Med; 1981 Sep 17; 305(12):663-7. PubMed ID: 6267464
    [Abstract] [Full Text] [Related]

  • 24. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
    Maroulis GB, Abraham GE.
    Obstet Gynecol; 1976 Aug 17; 48(2):150-4. PubMed ID: 133306
    [Abstract] [Full Text] [Related]

  • 25. Feedback control of gonadotropin secretion in mammalian and human males: effects of gonadotropin receptor blockers.
    Reznikov A.
    Endocrinol Exp; 1990 Mar 17; 24(1-2):267-73. PubMed ID: 2113858
    [Abstract] [Full Text] [Related]

  • 26. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP.
    J Pharmacol; 1983 Mar 17; 14 Suppl 3():117-35. PubMed ID: 6423907
    [Abstract] [Full Text] [Related]

  • 27. Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.
    Redding TW, Schally AV.
    Prostate; 1985 Mar 17; 6(3):219-32. PubMed ID: 3157927
    [Abstract] [Full Text] [Related]

  • 28. Changes in plasma steroid levels after single administration of hCG or LHRH agonist analogue in dog and rat.
    Tremblay Y, Belanger A.
    J Steroid Biochem; 1985 Mar 17; 22(3):315-20. PubMed ID: 2581068
    [Abstract] [Full Text] [Related]

  • 29. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
    Abraham GE, Maroulis GB.
    Obstet Gynecol; 1975 Mar 17; 45(3):271-4. PubMed ID: 163457
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer.
    Bélanger A, Dupont A, Labrie F.
    J Clin Endocrinol Metab; 1984 Sep 17; 59(3):422-6. PubMed ID: 6086697
    [Abstract] [Full Text] [Related]

  • 31. Treatment of prostate cancer with gonadotropin-releasing hormone agonists.
    Labrie F, Dupont A, Bélanger A, St-Arnaud R, Giguère M, Lacourcière Y, Emond J, Monfette G.
    Endocr Rev; 1986 Feb 17; 7(1):67-74. PubMed ID: 3514203
    [Abstract] [Full Text] [Related]

  • 32. Seventy-two hour infusions of LHRH in normal men: gonadotropin and testicular steroid responses.
    McNeil LW, McKenna TJ, Lacroix A, Benveniste R, Rabin D.
    J Clin Endocrinol Metab; 1979 Jul 17; 49(1):149-51. PubMed ID: 156193
    [Abstract] [Full Text] [Related]

  • 33. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.
    Moorjani S, Dupont A, Labrie F, Lupien PJ, Gagné C, Brun D, Giguère M, Bélanger A, Cusan L.
    J Clin Endocrinol Metab; 1988 Feb 17; 66(2):314-22. PubMed ID: 3276721
    [Abstract] [Full Text] [Related]

  • 34. Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma.
    Dupont A, Labrie F, Giguere M, Borsanyi JP, Lacourciere Y, Bergeron N, Cusan L, Belanger A, Emond J.
    Eur J Cancer Clin Oncol; 1988 Apr 17; 24(4):659-66. PubMed ID: 3289945
    [Abstract] [Full Text] [Related]

  • 35. [Hormonal and clinical efficacy of (D-Leu6)-des Gly-NH2(10)-LH.RH ethylamide against prostatic cancer].
    Imai K, Kumasaka F, Kobayashi M, Suzuki T, Takahashi O, Yamanaka H.
    Hinyokika Kiyo; 1985 Dec 17; 31(12):2302-6. PubMed ID: 2938456
    [Abstract] [Full Text] [Related]

  • 36. Radical prostatectomy: influence on serum and urinary androgen levels.
    Olsson M, Ekström L, Schulze J, Kjellman A, Akre O, Rane A, Gustafsson O.
    Prostate; 2010 Feb 01; 70(2):200-5. PubMed ID: 19760638
    [Abstract] [Full Text] [Related]

  • 37. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2396-402. PubMed ID: 9253307
    [Abstract] [Full Text] [Related]

  • 38. Role of androgens in the regulation of the human menstrual cycle.
    Rossmanith WG, Schenkel B, Benz R.
    Gynecol Endocrinol; 1994 Sep 01; 8(3):151-9. PubMed ID: 7847099
    [Abstract] [Full Text] [Related]

  • 39. A pure antiandrogen does not interfere with the LHRH agonist-induced blockade of testicular androgen secretion in the dog.
    Lacoste D, St-Arnaud R, Bélanger A, Labrie F.
    Mol Cell Endocrinol; 1988 Mar 01; 56(1-2):141-7. PubMed ID: 3286322
    [Abstract] [Full Text] [Related]

  • 40. Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist.
    Lefebvre FA, Bélanger A, Pelletier G, Labrie F.
    J Androl; 1984 Mar 01; 5(3):181-92. PubMed ID: 6086556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.